Heart Rate Variability and Cardiovascular Fitness: What We Know so Far

Código QR

Heart Rate Variability and Cardiovascular Fitness: What We Know so Far

Hugo Celso Dutra Souza, Stella Vieira Philbois, Ana Catarine Veiga, Bruno Augusto Aguilar Department of Health Science, Ribeirão Preto Medical School of University of São Paulo, São Paulo, BrazilCorrespondence: Hugo Celso Dutra SouzaRibeirão Preto Medical School, University of São Paulo, Laboratory...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Souza HCD, Philbois SV, Veiga AC, Aguilar BA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	heart rate variability cardiovascular fitness Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/2b271c8a1a4b4de2b5cd5460fa476113
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

TAVI in nonagenarians, what do we know so far?
por: Pablo Díez-Villanueva, et al.
Publicado: (2021)

What cardiologists need to know about cardiovascular magnetic resonance (CMR)
por: J. Cameron Bridgman, et al.
Publicado: (2017)

Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
por: Giandomenico Bisaccia, et al.
Publicado: (2021)

Associations Between Cardiorespiratory Fitness, Cardiovascular Risk, and Cognition Are Mediated by Structural Brain Health in Midlife
por: Goretti España‐Irla, et al.
Publicado: (2021)

Identifying High-Risk NASH Patients: What We Know so Far
por: Schulz M, et al.
Publicado: (2020)

Effects of Algorithmic Music on the Cardiovascular Neural Control
por: Alfredo Raglio, et al.
Publicado: (2021)

Vitamin E and Alzheimer’s disease: what do we know so far?
por: Browne D, et al.
Publicado: (2019)

Spaceflight-induced neuroplasticity in humans as measured by MRI: what do we know so far?
por: Angelique Van Ombergen, et al.
Publicado: (2017)

Screening of Pathophysiological Mechanisms and Psychological and Occupational Factors, Determining Risk of Cardiovascular Diseases in High-Risk Professions
por: Nikolova R., et al.
Publicado: (2020)

Risk factors for diabetic autonomic cardiovascular neuropathy in children and adolescents with type 1 diabetes mellitus
por: Maria Rustemovna Shaidullina, et al.
Publicado: (2013)

Cardiovascular clinical trials in Africa: opportunities and challenges
por: Marli Terblanche, et al.
Publicado: (2017)

Identification of a High-Risk Group of New-Onset Cardiovascular Disease in Occupational Drivers by Analyzing Heart Rate Variability
por: Ying-Chuan Wang, et al.
Publicado: (2021)

Cell Cycle, Telomeres, and Telomerase in <i>Leishmania</i> spp.: What Do We Know So Far?
por: Luiz H. C. Assis, et al.
Publicado: (2021)

Black students applying and admitted to medicine in the province of Quebec, Canada: what do we know so far?
por: Jean-Michel Leduc, et al.
Publicado: (2021)

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
por: Felipe Martínez
Publicado: (2021)

Methodist DeBakey cardiovascular journal

Effects of vagotomy on cardiovascular and heart rate variability alterations following chronic normobaric hypoxia in adult rabbits
por: Alcayaga,Julio, et al.
Publicado: (2018)

Effects of an exercise and sport intervention among refugees living in a Greek refugee camp on mental health, physical fitness and cardiovascular risk markers: study protocol for the SALEEM pragmatic randomized controlled trial
por: Markus Gerber, et al.
Publicado: (2021)

American journal of cardiovascular drugs drugs, devices, and other interventions.
Publicado: (2001)

Higher cardiorespiratory fitness predicts long-term survival in patients with heart failure and preserved ejection fraction: the Henry Ford Exercise Testing (FIT) Project
por: Olusola A. Orimoloye, et al.
Publicado: (2019)

Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger
por: Anshul S. Jadli, et al.
Publicado: (2021)

Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension
por: Alexander V. Sobolev, et al.
Publicado: (2021)

Which Microbes Like My Diet and What Does It Mean for My Heart?
por: Emilia Sawicka-Śmiarowska, et al.
Publicado: (2021)

Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic Coarctation
por: Timion A. Meijs, et al.
Publicado: (2021)

Predictors and diagnosis of cardiac autonomic nervous dysfunction in patients with type 1 and type 2 diabetes mellitus
por: Kirill A. Popov, et al.
Publicado: (2017)

U-Shaped Association of the Heart Rate Variability Triangular Index and Mortality in Hemodialysis Patients With Atrial Fibrillation
por: Matthias C. Braunisch, et al.
Publicado: (2021)

Meditation and Cardiovascular Health: What is the Link?
por: Sebastian Schnaubelt, et al.
Publicado: (2019)

Lifestyle Modification Using a Wearable Biometric Ring and Guided Feedback Improve Sleep and Exercise Behaviors: A 12-Month Randomized, Placebo-Controlled Study
por: Jonathan D. Browne, et al.
Publicado: (2021)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Michael T. Osterholm, et al.
Publicado: (2015)

Public spending and the poor: what we know, what we need to know
por: Van de Walle, Dominique
Publicado: (2014)

Cardiovascular fitness and cardiovascular risk factors among obese men and women aged 58 years and older, in Portugal
por: Araújo F,Rômulo, et al.
Publicado: (2012)

Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action
por: Zuraini NZA, et al.
Publicado: (2021)

The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies
por: Jingxuan Quek, et al.
Publicado: (2021)

COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review
por: Naz Sumaira, et al.
Publicado: (2021)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Mahendra Rai, et al.
Publicado: (2021)

Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
por: Bilal Abdulmawjood, et al.
Publicado: (2021)

What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries
por: Robert Sykes, et al.
Publicado: (2021)

Biomarker profile and risk stratification in cardiovascular disease during pregnancy: Action to move forward
por: Hasan Ali Farhan, et al.
Publicado: (2021)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Gianluigi Savarese
Publicado: (2019)

A Decade of Mighty Lipophagy: What We Know and What Facts We Need to Know?
por: Muhammad Babar Khawar, et al.
Publicado: (2021)